AA amyloidosis treated with tocilizumab: case series and updated literature review

Alice CourtiesRheumatology Department, Saint-Antoine Hospital, Inserm UMR S_938, UPMC, Univ Paris 06, Assistance Publique–Hôpitaux de Paris (AP-HP), Inflammation-Immunopathology-Biotherapy Departement (DHU i2B), Paris, France,

Gilles GrateauInternal Medicine Department, Reference Center of Inflammatory Amyloidosis and Familial Mediterranean Fever, Tenon Hospital, AP-HP, Univ Paris 06, DHU i2B, Paris, France,

Peggy PhilippeRheumatology Department, Regional University Hospital, Lille Nord de France University, Lille, France,

René-Marc FlipoRheumatology Department, Regional University Hospital, Lille Nord de France University, Lille, France,

Leonardo AstudilloInternal Medicine Department, University Hospital Purpan, Toulouse, France,

Bérengère Aubry-RozierRheumatology Department, Center for Bone Diseases, Lausanne University Hospital, Switzerland,

Isabelle FabreguetRheumatology Department, Center for Bone Diseases, Lausanne University Hospital, Switzerland,

Wafki FahdRheumatology Department, University Hospital El Ayachi, Rabat, Salé, Morocco,

Olivier FainInternal Medicine Department, Jean Verdier Hospital, AP-HP, Paris, France,

Pascal GuggenbuhlRheumatology Department, INSERM UMR 991, F-35000 Rennes University 1, F- 35000 Rennes, France,

Eric HachullaInternal Medicine and Clinical Immunology Department, National Reference Center for Rare Autoimmune and Systemic Diseases, Regional University Hospital, Lille Nord de France University, Lille, France,

Thomas PapoInternal Medicine Department, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France,

Christophe RichezRheumatology Department, University Hospital of Bordeaux, Bordeaux, France,

Jean SibiliaRheumatology Department, Hautepierre University Hospital, Strasbourg, France, and

Jacques MorelRheumatology Department, Lapeyronie University Hospital, Montpellier University, Montpellier, France

Francis BerenbaumRheumatology Department, Saint-Antoine Hospital, Inserm UMR S_938, UPMC, Univ Paris 06, Assistance Publique–Hôpitaux de Paris (AP-HP), Inflammation-Immunopathology-Biotherapy Departement (DHU i2B), Paris, France,

Jérémie SellamRheumatology Department, Saint-Antoine Hospital, Inserm UMR S_938, UPMC, Univ Paris 06, Assistance Publique–Hôpitaux de Paris (AP-HP), Inflammation-Immunopathology-Biotherapy Departement (DHU i2B), Paris, France, Correspondence[email protected]

& on behalf of the Club Rhumatismes Inflammation and the REGATE Registry show all

AA amyloidosis treated with tocilizumab: case series and updated literature review

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

AA amyloidosis treated with tocilizumab: case series and updated literature review

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date